Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Newstrike Brands Ltd NWKRF

"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."

OTCPK:NWKRF - Post Discussion

Newstrike Brands Ltd > Aurora does not control Cannimed or Newstrike, what is next
View:
Post by MartialArts on Jan 19, 2018 11:34am

Aurora does not control Cannimed or Newstrike, what is next

It's critical that investors and traders alike read and understand the press releases and agreements here.  ACB wasn't successful in it's hostile take over of CMED.  CMED holds the cards and aces but unfortuately the market doesn't do deep research to understand the complexities.

The merger agreement between HIP and CMED are binding if and only if, shareholder approval is received.  The breakup fee is if there is a superior offer, for example, from ACB, APH or WEED (the top three).

The relatively small breakup fee is if, for example, CMED agrees to merge with ACB and now, there is a chance of this. HIP has already agreed to merge, CMED is saying "wait a second, we'll get ACB a change to really come to the table".  HIP issues a "we're ok with it"  because if ACB steps in, the value goes up.

ACB is close to a $6B company in market cap.  So the $10M is peanuts for them, they have just issued $200M of new debenditures (debt tradable for $14 ACB shares), so paying the break up fee as part of a CMED takeover is nothing.

What matters here is ACB and CMED are now talking.  The November ratio was 4.53 ACB shares for each CMED shares but it was capped. That is what killed the deal, otherwise all shareholders would have voted yes.  The cap prevented CMED holders from benefiting from the sector appreciation caused by alcohol companies getting involved in this sector, M&A activity and now BMO getting into the game underwriting this sector. The cap killed the hostile take over.  These are trickly to do in a highly volatile environment.  

BMO getting into weed stocks is BIG NEWS!  Other banks will follow.  Very bullish if you jump on VALUE and value today is sub $1B market cap.  There's a handful of player at that value price but CMED stands out.  That's why 90%+ of HIP said YES!

Today ACB trades $13.40 so the ratio would value (uncapped) CMED at $60.70 (double what it trades at).

So assuming a big buyout which Aurora would support since it puts them in #1 spot ahead of WEED.TO, you have Aurora buying CMED at $60+ per share, that puts HIP at $2 per share post mega, friendly merger.  

I welcome any intelligent responses from novices or experts alike.  I will not respond to kids trying to be the bullies in playground fights.  I don't even let pros come at me.
Comment by gbenga on Jan 19, 2018 11:51am
Touche.  My sentiments precisely.  Thanks for untangling some of the complexities
Comment by londonsate on Jan 19, 2018 11:57am
Agree every thing except the CMED price $60+,  remeber CEO of CMED said on BNN that he thinks CMED should be 40 to 50 not long ago, 60 is bit high
Comment by dorward on Jan 19, 2018 12:13pm
I'm a newbie here, but doesn't your $2 a share forecast of HIP assume that HIP stays part of cannimed? just because cannimed agrees to a deal with ACB doesn't mean HIP will be in the mix. they could walk away from the deal with HIP and then HIP gets left out, making the price of HIP drop. Am i understanding this correctly?
Comment by MartialArts on Jan 19, 2018 3:33pm
Yes, CMED could walk away.  But ACB is in big time acquisition move and the UP Cannabis brand gives them an edge WEED.TO doesn't have. Remember, ACB wants to be #1 and from all indications, if they play their cards right, they will get CMED on board and HIP as well.
Comment by Green2017 on Jan 19, 2018 3:28pm
MARSHALARTS IS A FOOL PUT ON IGNORE, IF CMED HAD THE VOTES TO MERG WITH HIP, ZETTLE WOULDNT BE TALKING TO ACB, ACB IS IN THE DRIVER SEAT
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities